Industry Summit

The MedCan 2022 Industry Summit will help local companies accelerate their path to market through valuable insights into exporting, innovation and education. Industry experts will be presenting the latest scientific findings and breakthrough technologies and exploring the current challenges and opportunities around the likes of cultivating, manufacturing, New Zealand regulations, export, clinical trials, prescription and investment.  

Day 1 – Industry Summit – 10 February

Carmen Doran Chief Executive Officer, Helius Therapeutics
Eva Neshat Founder and Chief Executive Officer, Elysian Pharmaceuticals & CannaCare Clinic
Zoë Reece Founder and CEO, Ora Pharm
Dr Dottie Clower Chief Scientific Officer, Puro

This panel showcases some key players in New Zealand’s primary industries and how they are harnessing their brand story and aligning it with New Zealand’s story. This panel will shed light on the value chain opportunity and how medicinal cannabis can follow suit.
● Using New Zealand’s clean green image, in the local medicinal cannabis industry – how can we leverage this for our value chain?
● Coming together and collaborating to advocate for the industry – what is the opportunity here?


This presentation will highlight the commercial potential for medicinal cannabis or hemp beyond its primary use by taking a ‘whole of resource’ approach. It will outline how the Bioresource Processing Alliance and research providers can help industry partners identify high-value opportunities from low-value biological resources.

Andrew Cameron Principal Consultant, Callaghan Innovation
Anna Yallop General Manager, Bioresource Processing Alliance
  • A glimpse into the journey of bringing a product in the market
  • The challenges and barriers faced in making this a reality
  • Specific challenges tackling different regulatory systems around the world
  • Breaking barriers in product to market strategies – what are the learnings?
  • The way forward

Peter Crock Chief Executive Officer, Cann Group

• Types of investment
• Trends
• Future of investments

Kristen Lunman Co-Founder and GM, Hatch